FOLD
Amicus Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website amicusrx.com
- Employees(FY) 484
- ISIN US03152W1099
Performance
+0.95%
1W
-9.37%
1M
-30.45%
3M
-9.72%
6M
-32.56%
YTD
-14.09%
1Y
Profile
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
Investment Analysis Report: FOLD
Overview
In this investment analysis report, we will delve into the financial statements of Amicus Therapeutics Inc. (FOLD), a pharmaceutical company operating in the Health Technology sector. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating c...
Technical Analysis of FOLD 2024-05-10
Overview:
In analyzing the technical indicators for FOLD over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-14 07:15
- 2024-05-10 16:03
- 2024-05-10 13:10
- 2024-05-10 11:33
- 2024-05-10 10:46
- 2024-05-10 04:03
- 2024-05-09 22:46
- 2024-05-09 22:30
- 2024-05-09 10:30
- 2024-05-09 08:25
- 2024-05-09 07:21
Amicus Therapeutics: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-09 07:00
- 2024-05-08 23:56
- 2024-05-08 20:26
- 2024-05-08 20:25
- 2024-05-08 19:00
- 2024-05-08 07:00
- 2024-05-07 19:00
- 2024-05-03 10:00
- 2024-05-01 10:01
- 2024-05-01 07:00
- 2024-04-30 22:01
- 2024-04-30 19:00
- 2024-04-19 10:27
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?(Simply Wall St.)
- 2024-03-29 11:30
- 2024-03-28 23:30
- 2024-03-25 21:53
WuXi Biologics Reports Solid 2023 Annual Results(Prnewswire)
- 2024-03-20 07:00
- 2024-03-19 19:00
- 2024-03-13 07:07
13 Best Biotech Stocks To Buy Under $20(Insider Monkey)
Page 1 of 6
previousnext